Advanced Search
Submit Manuscript Volume 32, No 6, Jun 2022
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 32 Issue 6, June 2022: 585-588 |
Generic amyloid fibrillation of TMEM106B in patient with Parkinson’s disease dementia and normal elders
Yun Fan1,† , Qinyue Zhao2,3,† , Wencheng Xia4,5,† , Youqi Tao2,3 , Wenbo Yu1 , Mingjia Chen1 , Yiqi Liu1 , Jue Zhao1 , Yan Shen1 , Yunpeng Sun4,5 , Chenfang Si4,5 , Shenqing Zhang2,3 , Yaoyang Zhang4,5 , Wensheng Li6 , Cong Liu4,5,* , Jian Wang1,* , Dan Li2,3,7,*
1Department of Neurology and National Research Center for Aging and Medicine & National Center for Neurological Disorders, State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, ChinaDear Editor,
Protein amyloid aggregation is a histological hallmark of neurodegenerative diseases (NDs).1,2 In synucleinopathies including Parkinson’s disease (PD), Parkinson’s disease dementia (PDD), dementia with Lewy body and multiple system atrophy, α-synuclein (α-syn) is commonly characterized to form amyloid aggregates presenting distinct pathological activities in diseased brains.3,4 Structural characterization of α-syn amyloid fibrils formed in different diseases could provide mechanistic understanding of heterogeneous α-syn pathologies.5,6
https://doi.org/10.1038/s41422-022-00665-3